Strategic Brand Dako is a key pathology solutions brand under Agilent Technologies with global hospital and research laboratory adoption, presenting a strong channel for expanding instrument, reagent, and software sales to existing customers and cross-sell opportunities within Agilent's installed base.

Expansion Potential With broad usage across hospitals and research labs and a sizable global footprint, there are opportunities to upsell higher-end pathology workflows, automation instruments, and advanced software to streamline tissue-based diagnostics and cancer treatment decisions.

Financial Scale Annual revenue in the multi-hundred million range indicates substantial purchasing power and potential for multi-year procurement contracts, service agreements, and bundled solution offers that lock in recurring revenue.

Tech Synergy Leveraging Agilent's ecosystem, there is potential to pair Dako reagents and instruments with complementary analytics software, AI-enabled pathology insights, and workflow automation to attract larger lab networks seeking integrated solutions.

Strategic Growth Ownership by Agilent and presence in a high-growth diagnostics space positions Dako to pursue collaborations with research centers and hospitals on standardized protocols, training services, and remote support could expand adoption and retention.